Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Parthika Patel

M. Pharm (Pharmaceutics)

Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Home

Parthika Patel

Articles By : Parthika Patel

Bombay HC Refuses Interim Shield to Pharma Firm in Snake Anti-Venom Case

Parthika Patel3 March 2026 9:12 PM IST

Panaji: The Bombay High Court has refused to grant interim relief to Aarav Pharma in a case concerning the alleged supply of spurious snake ant-venom...

560 Pharmacist Jobs Announced in Uttar Pradesh, Apply from March 9

Parthika Patel3 March 2026 9:04 PM IST

Lucknow: The Uttar Pradesh Subordinate Services Selection Commission (UPSSSC) has issued the official notification for UPSSSC Pharmacist Recruitment...

B.Pharm Student Killed After Speeding Trailer Rams Motorcycle in Indore

Parthika Patel3 March 2026 8:57 PM IST

Indore: A Bachelor of Pharmacy (B.Pharm) student lost his life after a speeding trailer rammed into his motorcycle in Indore, police stated.According...

Five Pharmacists Booked for Allegedly Selling Counterfeit Life-Saving Medicines

Parthika Patel2 March 2026 11:00 AM IST

Pune: The Vishrambaug police have registered a criminal case against five pharmacists for allegedly selling counterfeit medicines that were prescribed...

Mankind Pharma Gets Relief as CGST Appellate Authority Drops Rs 1.02 Cr Penalty

Parthika Patel1 March 2026 1:15 PM IST

New Delhi: Mankind Pharma Limited has received an order from the Additional Commissioner, CGST (Appeals), Meerut, Uttar Pradesh, dropping a penalty of...

Delhi Court Clears Aurobindo Promoter in High-Profile Excise Policy Probe

Parthika Patel1 March 2026 1:00 PM IST

New Delhi: P.Sarath Chandra Reddy, promoter and non-executive director of Aurobindo Pharma Limited, has been acquitted by a Delhi court in the alleged...

Meropenem, Ritonavir Back in Focus as DoP Reopens PLI Application Window Till March 12

Parthika Patel1 March 2026 12:45 PM IST

New Delhi: The Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers has re-opened the application window for select products...

Aurobindo Pharma's Eugia Unit-I Gets 4 USFDA Observations

Parthika Patel28 Feb 2026 9:00 PM IST

New Delhi: Aurobindo Pharma Limited on February 27, 2026 announced the completion of a United States inspection at its subsidiary's facility, stating...

Zydus Completes Pivotal Study for Keytruda Biosimilar, Prepares USFDA BLA Filing

Parthika Patel28 Feb 2026 8:45 PM IST

Ahmedabad: Zydus Lifesciences Limited has successfully completed the pivotal clinical development of its pembrolizumab biosimilar FYB206 and is...

MP GST Dept Slaps Rs 3.79 Crore Tax, Penalty Demand on GSK Pharma

Parthika Patel28 Feb 2026 8:30 PM IST

New Delhi: GlaxoSmithKline Pharmaceuticals Limited has received a GST demand order of Rs 3.79 crore from the Madhya Pradesh GST authorities after...

7 Pharma Firms Eye Generic Semaglutide, Prices May Fall 50% Post Patent Expiry: Report

Parthika Patel27 Feb 2026 7:40 PM IST

New Delhi: Prices of widely used weight-loss drugs such as Wegovy and Ozempic are expected to drop significantly in India after the semaglutide patent...

CDSCO Cancels Kult App's Cosmetic Import Registrations Over False Labeling

Parthika Patel27 Feb 2026 7:24 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has cancelled multiple registration certificates and import registration numbers...

Journal Club Today

Health News Today

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok